Summary of findings table ‐ Topical small molecule inhibitors (ruxolitinib) vs placebo
Short‐term hair regrowth ≥ 75% (between 12 and 26 weeks of · adults with alopecia areata
Summary of findings table ‐ Topical small molecule inhibitors… showed no clear difference in short‐term hair regrowth ≥ 75% (between 12 and 26 weeks of compared with placebo (low certainty).
1 finding from 1 review
- RR 5 [0.25, 100.89]1 study · 78 participantsLow